- Sanofi – Aventis Pakistan ltd. sales – net for the period increased by 3.38%, amounting to a total of 9.76 billion Rupees during the nine months ended September, 30th 2017
- Company’s Gross Profit for the period increased by 14% 3.6 bilion
- Company’s Administrative Expenses and Other operation costs increased by 31.22% and 131.45% respectively
- The Profit after tax for the period increased 56.16% reaching 974 million against last year’s nine months profits of Rs. 606 million
- The company’s basic earnings per share reached rupees 98.22 against 62.90 rupees in 2016
Unconsolidated Profit and Loss Account – For the Nine Months Ended, September 30th 2017 | |||
|---|---|---|---|
Key Financials | 2017 | 2016 | % Change |
Amounts in PKR ‘000 | |||
Net Sales | 9,767,953 | 9,448,593 | 3.38% |
Cost of Sales | 6,123,933 | 6,256,813 | -2.12% |
Gross Profit | 3,644,020 | 3,191,780 | 14.17% |
Dist: and Marketing Expenses | 1,613,300 | 1,603,527 | 0.61% |
Administrative Expenses | 294,998 | 224,807 | 31.22% |
Other operating expenses | 348,888 | 150,739 | 131.45% |
Other operating income | 35,858 | 27,331 | 31.20% |
Operating Profit | 1,422,692 | 1,240,038 | 14.73% |
Finance costs | 29,405 | 131,394 | -77.62% |
Profit before Taxation | 1,393,287 | 1,108,644 | 25.67% |
Taxation | 445,987 | 502,005 | -11.16% |
Net profit for the period | 947,300 | 606,639 | 56.16% |
Basic and diluted – EPS | 98.22 | 62.90 | 56.15% |
Company release on Earnings Report can be accessed here.
Posted on: 2017-10-27T11:13:00+05:00
